Skip to content

Feasibility study of OSTAP block combined with PCIA in improving analgesic effect and early rehabilitation after upper abdominal surgery

Feasibility study of OSTAP block combined with PCIA in improving analgesic effect and early rehabilitation after upper abdominal surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076955
Enrollment
Unknown
Registered
2023-10-25
Start date
2023-10-23
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesic and early rehabilitation

Interventions

OSTAPB+PCIA Group:Perform OSTAP block after anesthesia induction
PCIA Group:Not performing OSTAP block after anesthesia induction

Sponsors

The First Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective epigastrium surgery; 2. Patients aged 18-75; 3. American Society of Anesthesiologists (ASA) I–III; 4. Patients receiving bilateral OSTAP block without contraindications to local anesthetics; 5. The patient is able to understand the written informed consent document and has the willingness to sign it;

Exclusion criteria

Exclusion criteria: 1. Patients with cardiac, pulmonary, and renal dysfunction, as well as patients with Uncontrollable hypertension and diabetes, history of digestive hemorrhage, blood system diseases; 2. Emergency patients and patients with preoperative infections, or patients with a history of immune diseases, endocrine system diseases, or chemotherapy; 3.body mass index 30 kg/m2; 4. Surgery duration >8 hours; 5. Patients with allergic reactions to non-steroidal anti-inflammatory drugs (NSAIDs) or ropivacaine and bronchial asthma; 6. Long term use of painkillers (NSAIDs, opioids) or steroids for treatment, as well as patients with sensory abnormalities or peripheral neuropathy;

Design outcomes

Primary

MeasureTime frame
Mean VAS for rest and movement states at 0-3 days after surgery;

Secondary

MeasureTime frame
VAS of rest and movement at different time points after surgery;Intraoperative and postoperative opioid dosage;Dosage of various vasoactive drugs used during surgery;First self-controlled analgesia time;adverse events;Rehabilitation indicators;hospital stay;

Countries

China

Contacts

Public ContactAn Ke

The First Affiliated Hospital of Sun Yat-Sen University

anke@mail.sysu.edu.cn+86 158 0003 7306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026